Jim E. Eyles
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Endocrinology top 5%
Papers in
- Immunology 15
- Immunotherapy and Immune Responses 9
- Genetics 14
- Yersinia bacterium, plague, ectoparasites research 11
- Co-authors
- H. Oya Alpar (22 shared papers)E. Diane Williamson (11 shared papers)Ethel Diane Williamson (9 shared papers)Ian D. Spiers (8 shared papers)Vincent W. Bramwell (4 shared papers)Stephen J. Elvin (3 shared papers)Gareth David Healey (3 shared papers)Les W. J. Baillie (3 shared papers)
- Journals
- Vaccine (11 papers)Journal of Pharmacy and Pharmacology (5 papers)Journal of Controlled Release (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)Advanced Drug Delivery Reviews (2 papers)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Jim E. Eyles
50 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 260
- Endocrinology 107
- Virology 88
- Immunology 365
- Infectious Diseases 245
Countries citing papers authored by Jim E. Eyles
This map shows the geographic impact of Jim E. Eyles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim E. Eyles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim E. Eyles more than expected).
Fields of papers citing papers by Jim E. Eyles
This network shows the impact of papers produced by Jim E. Eyles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim E. Eyles. The network helps show where Jim E. Eyles may publish in the future.
Co-authors
The 25 scholars most cited alongside Jim E. Eyles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 99 | |
| 2 | 2001 | 96 | |
| 3 | 1998 | 87 | |
| 4 | 2002 | 85 | |
| 5 | 2001 | 84 | |
| 6 | 1998 | 60 | |
| 7 | 2006 | 54 | |
| 8 | 1995 | 52 | |
| 9 | 1999 | 49 | |
| 10 | 2005 | 48 | |
| 11 | 2001 | 44 | |
| 12 | 2000 | 36 | |
| 13 | 2005 | 36 | |
| 14 | 2000 | 33 | |
| 15 | 2007 | 33 | |
| 16 | 2000 | 33 | |
| 17 | 2003 | 32 | |
| 18 | 1997 | 29 | |
| 19 | 2018 | 29 | |
| 20 | 2004 | 26 |
About Jim E. Eyles
Jim E. Eyles is a scholar working on Immunology, Genetics, Pharmaceutical Science, Endocrinology and Infectious Diseases, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bacillus and Francisella bacterial research (12 papers), Yersinia bacterium, plague, ectoparasites research (11 papers), Immunotherapy and Immune Responses (9 papers), Advanced Drug Delivery Systems (6 papers), Inhalation and Respiratory Drug Delivery (5 papers), RNA Interference and Gene Delivery (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Pharmaceutical Science (260 citations), Endocrinology (107 citations), Virology (88 citations), Immunology (365 citations) and Infectious Diseases (245 citations). Jim E. Eyles has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include H. Oya Alpar, E. Diane Williamson, Ethel Diane Williamson, Ian D. Spiers, Vincent W. Bramwell, Stephen J. Elvin, Gareth David Healey, Les W. J. Baillie, Richard W. Titball and Gregory J.E. Sharp. Their work appears in journals such as Vaccine, Journal of Pharmacy and Pharmacology, Journal of Controlled Release, Journal for ImmunoTherapy of Cancer and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.